Answers are grounded in this paper and cite their sources.
Background: Oropharyngeal squamous cell carcinoma (OPSCC) is divided into two distinct disease entities, distinguished by p16 status, which confers significant prognostic benefit when positive (human papilloma virus-mediated). Limited data exist in low- and middle-income countries (LMICs) to correlate whether this translates to our setting, where lifestyle risk factors are rife such as heavy alcohol, tobacco consumption and poor socioeconomic status. Aim: This study aimed to evaluate the prevalence and compare overall survival (OS) of p16-positive and negative OPSCC within a LMIC setting. Setting: This single-centre study was conducted at Groote Schuur Hospital, Cape Town, South Africa. Methods: Retrospective observational study where data were collected on patients with OPSCC from January 2017 to December 2020, exploring prevalence and OS at 3-years in patients treated with curative intent. Demographic and lifestyle factors were analysed to identify statistical significance. Results: A total of 190 patients were included. Prevalence of p16-positive OPSCC was 20.8%. A total of 111 patients were treated with curative intent: 3-year OS in patients with p16-positive was 57% (median OS 59 months, 95% confidence interval [CI]: 0.00–120.16) and p16-negative patients 33% (median OS 16 months, 95% CI: 11.85–20.15), which is statistically significant (p = 0.03). Conclusion: P16-positive OPSCC has superior OS compared to p16-negative OPSCC, with lower prevalence compared to developed countries. Contribution: P16-positive OPSCC comprises an important minority (20.8%) of OPSCC where p16 status, smoking and alcohol consumption are the most important prognostic factors.
No takes yet. Share an insight, caveat, or question.
Riet et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: